教育背景及培训经历：

1.    1984-1990，北京大学医学部，医学博士；

2.    1990-1995，北京大学医学部，病理住院医师；

3.    2000-2002，纽约大学医学院皮肤科，从事博士后研究工作；

4.    2003-2009，纽约大学医学院病理系，副研究员；

5.    2009-2013，纽约大学医学院病理系，病理专科医师；

6.    2013-2014，纽约Sloan-Kettering纪念癌症中心病理系，肿瘤外科病理医师；

7.    2014-2015，纽约大学Langone医学中心病理系，泌尿病理专科医师。

学术背景：

1.    1995-2000，北京大学医学部泌尿研究所病理研究室，助理教授；

2.    2000.7-2000.8，北京大学医学部泌尿研究所病理研究室，副教授。

资质和认证：

1.    1990年，北京大学医学部，医学博士；

2.    2013年，纽约大学医学院，病理专科医师资格；

3.    2013年，美国病理学委员会，解剖和临床病理资格；

4.    2013-3-14，美国国家医师执照（编号：269195）；

5.    2014，纽约Sloan-Kettering纪念癌症中心，肿瘤外科病理医师资格；

6.    2014-2016，纽约州卫生部门颁发行医资格证书；

7.    2015-至今，新墨西哥州卫生部门颁发行医资格证书。

学会任职：

1.    美加病理学会，委员；

2.    国际泌尿病理学会，委员；

3.    美国病理医师学院，委员；

4.    美国华人医师学会，委员；

5.    美国临床病理学会，委员；

6.    美国医学会，委员。

荣誉和奖励：

1.    2010-01，国际泌尿病理学会奖励；

2.    2010-05，美国华人医师学会，三等奖；

3.    2010-11，美国马里兰州巴尔的摩市，国际泌尿病理学会资助从师Dr. Jonathan Epstein博士（约翰霍普金斯医院）专修泌尿专科病理；

4.    2014-03，国际泌尿病理学会优秀泌尿病理专科医师奖。

授课经历：

1.    1995-2000，北京大学医学部讲授病理学；

2.    2009-2013，纽约大学讲授头颈部病理、胸部病理、胃肠病理、血液病理、神经病理等；

3.    2013/10，纽约Sloan-Kettering纪念癌症中心讲授“骨化性肌炎样软组织动脉瘤样骨囊肿”。

其它专业活动：

1.    2008/12，芝加哥大学病理系，受邀发表“前列腺腺癌诊断中冰冻切片分析的应用”演讲；

2.    2011年，“北美医学与科学杂志”的同行评议专家。

发表的论文和专著

1. Huang CC , Kong MX,Zhou M, Rosenkrantz AB, Taneja SS, Melamed J, and Deng FM. Gleason Score 3+4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.Am J SurgPathol. 2014 May 28. PMID: 24832163

2. Kong MX, Hale C,Subietas-Mayol A, Lee P, Cassai ND, McRae G, Goldfarb DS, Zhou M, Wieczorek R.Bilateral tubulocystic renal cell carcinomas in diabetic end-stage renal disease: first case report with cytogenetic and ultrastructural studies. Rare tumors 2013; 5:185-188 PMID: 24416491

3. Bosland MC, Kato I, Zeleniuch-Jacquotte Anne, Schmoll J, Enk Rueter E, Melamed J, Kong MX, Macias V, Kajdacsy-Balla A, Lumey LH, Xie H, Gao W, Walden P, Lepor H, Taneja SS, Randolph C, Schlicht MJ, Meserve-Watanabe H, Deaton RJ, Davies JA. Effect of Soy Protein Isolate Supplementation on Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy: A Randomized Placebo-Controlled Trial. JAMA 2013;310(2):170-178. PMID: 23839751

4. Deng FM, Zhao Y, Kong X, Lee P, Melamed J. Construction of tissue microarrays using pre-existing slides as source of tissue when paraffin blocks are unavailable. J Clin Pathol. 2013 Mar 9. PMID: 23476078

5. Kong MX, Zhao X, Kheterpal E, Lee P, Taneja S, Melamed J, Deng FM. Histopathologic and clinical features of vesical diverticula. Urology. 2013 Mar 26. pii: S0090-4295(13)00213-6. doi: 10.1016/j.urology.2013.02.015. PMID: 23540860

6. Rosenkrantz AB, Mussi TM, Hindman H, Lim RP, Kong MX, Babb JS, Melamed J, Taneja SS. Prostate Cancer: Impact of Post-Biopsy Hemorrhage and Delay after Biopsy on Tumor Detection using Multi-parametric MRI-A Multi-Reader Study. Clinical Radiology. 2012, 67, e83-e90. PMID: 22981729

7. Liu HG, Kong MX, Yao Q, Wang SY, Martiniuk F, Shibata R, Yee H, Wang BY. Expression of Sox10 and c-kit in Sinonasal Mucosal Melanomas arising in the Chinese population. Head and neck pathology Journal. 2012, 6(4):401-408 PMID: 22736149

8. Kong MX, Newman K, Goldenburg R, Tierno PM, Mikolaenko I, and Rapkiewicz A. Fatal mycoplasma pneumoniae infection: case report and review of the literature. North American Journal of Medicine and Science. 2012 April; 5(2):126-30.

9. Rosenkrantz AB, Mannelli L, Kong X, Niver BE, Berkman DS, MD, Babb JS, Melamed J, and Taneja SS. Prostate Cancer: Utility of Fusion of T2-Weighted and High b-Value Diffusion-Weighted Images for Peripheral Zone Tumor Detection and Localization. Journal of Magnetic Resonance Imaging. 2011; 34:95-100 PMID: 21698707

10. Ye H, Kong X, He TW, Jolis T, Choi K, Lepor H, Melamed J. Intraoperative Frozen Section Analysis of Urethral Margin Biopsies During Radical Prostatectomy. Urology. 2011 May 28; 78(2):399-404 PMID:21624646

11. Rosenkrantz AB, Kong X, Niver BE, et al. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map. AJR Am J Roentgenol. 2011 Jan; 196(1):123-9. PMID: 21178056

12. Rosenkrantz AB, Kopec M, Kong X, Melamed J, Dakwar G, Babb J, Taouli B. Prostate Cancer versus Post-Biopsy Hemorrhage: Diagnosis with T2- and Diffusion-Weighted Imaging. Journal of Magnetic Resonance Imaging. 2010; 31:1387-1394. PMID: 20512891

13. Rosenkrantz AB, Neil J, Kong X, et al. Prostate Cancer: Comparison of 3D T2-Weighted With Conventional 2D T2-Weighted Imaging for Image Quality and Tumor Detection. AJR Am J Roentgenol. 2010 Feb; 194(2):446-52. PMID: 20093608

14. Xu K, Shimelis H, Linn DE, Jiang R, Yang X, Sun F, Guo Z, Chen H, Li W, Chen H, Kong X, Melamed J, Fang S, Xiao Z, Veenstra TD, Qiu Y. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell. 2009 Apr 7; 15(4):270-82. PMID: 19345326

15. Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung HJ, Brodie AM, Edwards J, Qiu Y. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgendepletion-resistant growth. Cancer Res. 2009, 69:2305-13. PMID: 19244107

16. Peng Y, Chen F, Melamed J, Chiriboga L, Wei J, Kong X, McLeod M, Li Y, Li CX, Feng A, Garabedian MJ, Wang Z, Roeder RG, Lee P. Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer. Proc Natl Acad Sci U S A. 2008; 105:5236-5241. PMID: 18356297

17. You Z, Dong Y, Kong X, Beckett LA, Gandour-Edwards R and Melamed J. Midkine is a NF-κB-inducible gene that supports prostate cancer cell survival. BMC Medical Genomics 2008, 1:6-16.PMID: 18275606

18. You Z, Dong Y, Kong X, Zhang Y, Vessella RL and Melamed J. Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers. Neoplasia 2007; 9:464-470. PMID: 17603628

19. Kong X, Zhao Y, Ksionsk M, Zhou M, Walden P, Bosland MC, Pei Z, Lee P, Melamed J. Radiographic determination of tissue thickness in paraffin blocks: Application to the construction of tissue microarrays. Applied Immunohistochemistry & Molecular Morphology, 2007; 15:108-112. PMID: 17536317

20. Kajdacsy-Balla A, Geynisman JM, Macias V, Setty S, Nanaji NM, Berman JJ, Dobbin K, Melamed J, Kong X, Bosland M, Orenstein J, Bayerl J, Becich MJ, Dhir R, Datta MW; The Cooperative Prostate Cancer Tissue Resource. Practical aspects of planning, building, and interpreting tissue microarrays: The Cooperative Prostate Cancer Tissue Resource experience. J Mol Histol. 2007 May;38(2):113-21. PMID: 17318343

21. Guo Z, Dai B, Jiang T, Xu K, Xie Y, Kim O, Nesheiwat I, Kong X, Melamed J, Handratta VD, Njar VCO, Brodie AMH, Yu LR, Veenstra TD, Chen H, and Qiu Y. Regulation of Androgen Receptor by Tyrosine Phosphorylation. Cancer Cell 2006;10:309-319. PMID: 17045208

22. Dai B, Kim O, Xie Y, Guo Z, Xu K, Kong X, Melamed J, Chen H, Bieberich CJ, Borowsky AD, Kung HJ, Wei G, Ostrowski MC, Brodie A, and Qiu, Y. Tyrosine Kinase Etk/Bmx Is Upregulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse. Cancer Research 2006; 66: 8058-8064. PMID: 16912182

23. Kong XT, Deng FM, Hu P, Liang FX, Zhou G, Auerbach AB, Genieser N, Nelson PK, Robbins ES, Shapiro E, Kachar B, and Sun TT. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. Journal of Cell Biology 2004;167:1195-1204. PMID: 15611339

24. Li S, Kong X,Shan G. Ultrasonographic manifestations and histological structures of prostate adenocarcinoma. Chinese Journal of Ultrasound Medicine 2001 March,17(3):334-336.

25. Zeng L, Kong XT,Su JW, Xia TL, Na YQ, Guo YL. Evaluation of germ-cell kinetics in infertilepatients with proliferating cell nuclear antigen proliferating index. Asian J Androl 2001 March;3(1):63-66. PMID: 11250796

26. Kong X, Zeng L,Mi P. Carcinoma of kidney collecting duct: an analysis of 10 cases. Zhonghua Zhong Liu Za Zhi 2001 March;23(2):162-164. PMID: 11783026

27. Kong X, Zeng L,Mi P, et al. The clinical and pathological manifestations of papillary renal cell carcinoma. Chin J Urol 2001Jan; 22(1):77-80.

28.Kong X, Zeng L, Xia T, et al. Evolution of stromal nodules in benign prostatic hyperplasia. Journal of Beijing Medical University 2000;32(4):378-380.

29. Kong X, Zeng L, Yang Y, Xia T, Gu FL, Guo YL,and Lee C. Immunohistochemical characterization of stromal nodules in benign prostatic hyperplasia. The Prostate Journal 2000;2(4):199-204.

30.Kong X, Xi Z, Mi P, et al. Correlation between expression of urothelial differentiation-associated uroplakin and differentiation of bladder transitional cell carcinoma. Chinese Journal of Urology 2000;21:134-136.

31. Wang S, Xia T, Zhang Z, Kong X, Zeng L, Mi P, Xue Z. Expression of VEGF and tumor angiogenesis in bladder cancer. Zhonghua Wai Ke Za Zhi. 2000 Jan;38(1):34-6. PMID: 11831983

32. Kong X, Tu P, Li J, et al. The value of Ca15-3 in differential diagnosis of Paget’s disease. Journal of Beijing Medical University 1999;31:426-428.

33. Kong X, Zeng L, Xia T, Wang J, Mi P, Na Y, Xue Z, Pan B, Hao J, Gu FL, Guo YL. The effect of combined endocrine therapy on prostate and testis. Zhonghua Wai Ke Za Zhi 1999 April;37(4):231-234. PMID: 11829828

34. Kong X, Li J, Xue Z, Zeng L, Shen L, Xia T, Gu F, and Guo Y. Clinicopathologic study of 11 patients with Paget's disease of scrotum. Zhonghua Wai Ke Za Zhi. 1999 Jul;37(7):424-6. PMID: 11829879

35. Zeng L, Xia T, Kong X, Gu F. Massive lipoma of the scrotum. Chin Med J(English). 1999 Jan;112(1):84-5. PMID: 11593649

36. Jiang XJ, Feng T, Chang LS, Kong XT, Wang G, Zhang ZW, Guo YL. Expression of osteopontin mRNA in normal and stone-forming rat kidney. Urol Res 1998;26:389-94.

37. Kong X, Xia T, Zeng L. A study of fat content and its local distribution in misdiagnosed renal angiomyolipoma. Chinese Journal of Urology 1998;19:658-659.

38. Jin J, Guo B, Kong X. Multilocular cyst of kidney. Zhonghua Wai Ke Za Zhi. 1998;36:57-8.

39. Li H, Yu L, Yang B, Kong X, Mi P, Guo Y. Expression and significance of Fas/APO-1 and bcl-2 protein in renal cell carcinoma. Zhonghua Wai Ke Za Zhi. 1998 Jul;36(7):409-11. PMID:11825426

40. Yang B, Gu F, Li H, Kong X, Yu L. Apoptosis of renal cell carcinoma and apoptotic related genes bcl-2 and bax. Zhonghua Wai Ke Za Zhi. 1998 Jun;36(6):373-5. PMID: 11825416

41. Pan B, Song Y, Kong X, Xue Z, Guo Y. Primary epididymal tumors. Zhonghua Wai Ke Za Zhi. 1998 Mar;36(3):138-40 PMID: 11825350

42. Ding Y, Kong X, Yu L, et al. Reversion of drug resistance in intrinsic drug resistance cell line GRC-1. Chinese Journal of Urology 1997, 18:651-653.

43. Kong X, Xia T and Gu F. Study of the latent carcinoma of Prostate in China. Br J Urol 1997 Sept;80(suppl 2):229.

44. Kong X, Ding Y, Xia T. Drug resistance and its mechanism of intrinsic drug-resistant cell line GRC-1. Zhonghua Wai Ke Za Zhi 1997 Nov;35(11):697-9. PMID: 10678018

45. Zhong H, Deng F, Kong X. Expression of basic fibroblast growth factor and its receptor in renal cell carcinoma. Zhonghua Wai Ke Za Zhi 1996 Nov;34(11):651-4. PMID: 9590749

46. Kong X, Xia T, Mi P. The diagnosis of prostatic cancer by transrectal fine needle aspiration. Chinese Journal of Pathology 1996;25:244-245.

47. Kong X, Xia T, Gu F. Expression of mdr1 messenger RNA in human renal cell carcinomas. Chinese Journal of Urology 1996;17:330-332.

48. Kong X, Deng F, Wang J. The application of high molecular weight cytokeratin in differential diagnosis of prostate adenocarcinoma. Zhonghua Bing Li Xue Za Zhi 1996 Aug;25(4):199-201. PMID:9275650

49. Kong X, Xia T, Gu F. Expression of mdr-1 gene product in primary renal cell carcinoma and its clinical significance. Chinese Journal of Urology 1995;16:329-331.

50. Gu FL, Xia TL, Kong XT. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology 1994 Nov;44(5):688-91. PMID: 7526525

51. Kong X, Zou WZ, Wang CS. Comparison of kidney structure in young with old mice and the effect of kidney nourishing recipes on the glomerular basement membrane. Chinese Journal of Geriatric Medicine 1994, 13:53-55.

52. Xia T, Kong X, Su J. Pathogenesis and histopathology of benign prostate hyperplasia in adult Chinese. Chinese Journal of Urology 1993, 14:415-417.

53. Kong X, Xia T, Ma W. The clinicopathological features of testis tumors. Chinese Journal of Urology 1993, 14:375-8. Books, Chapters

54. Kong, X. (1996). Pathology of prostate. In Modern Prostate Disease. By Gu, X. and Pan, B. (Beijing Medical University Press, Beijing, China, ISBN 7-81034-551-6), pp52-138.

55. Kong, X. and Guo, Y. (1998). The pathologic diagnosis of prostatic cancer. In Benign Prostate Hyperplasia and Prostate Cancer. By Guo, Y. (The People’s Public Health Press, Beijing, China,ISBN 7-117-03020-8), pp194-202.

56. Kong, X. and Xia,T. (2000). Fine needle aspiration of prostate, kidney, and adrenal gland. In Diagnostic Cytopathology. By Ma, Z., Kan, X., and Liu, S. (Henan Science and Technical Publishing House, Zhengzhou, China, ISBN 7-5349-2030-2), pp615-627.

57. Kong, X. and Xia, T. (2002). Testis tumor. In Contemporary Urologic Pathology. By Xia, T. (The People’s Public Health Press, Beijing, China, ISBN 7-117-04979-0), pp360-393.

58. Sun, T.T., Kong, X., Deng, F.M., and Liang, F.X. (2002). Uroplakins and the diseases of urinary tract. In Modern Prostate Disease. By Xia, T. (The People’s Public Health Press, Beijing, China, ISBN 7-117-04979-0), pp751-760.

Abstracts

1. Kong M, Brannon AR, Won H, Gandhi A, Al-Ahmadie HA, Fine SW, Gopalan A, Russo P, Berger MF, Tickoo SK, Ying-Bei Chen YB. mTOR Pathway Activation Characterizes a Subset of Unclassified Renal Cell Carcinoma: Immunohistochemical, Molecular and Histologic Analysis. The 103rd USCAP annual meeting, San Diego, California, USA. Mar. 1-7, 2014.

2. Kong M, Drill E, Klimstra D, Ghossein R, Gonen M and Katabi N. Proliferative grading predicts outcome in myoepithelial Carcinoma of Salivary Glands: A Clinicopathologic Study of 48 cases. The 103rd USCAP annual meeting, San Diego, California, USA. Mar. 1-7, 2014.

3. Huang CC, Kong M, Ren Q, Deng FM, Melamed J, Zhou M. Prostate cancer multifocality and heterogeneity: Implications for Gleason grading, tumor volume measurement and tissue sampling for research. The 102nd USCAP annual meeting, Baltimore, Maryland, USA. Mar. 2-8, 2013.

4. Ren Q, Kong MX, Wu X, Deng FM, Melamed J, Monaco ME, Lee P. Role of Long-chain fatty Acyl-CoA synthetase 4(ACSL4) in prostate cancer progression. The 102nd USCAP annual meeting, Baltimore, Maryland, USA. Mar. 2-8, 2013.

5. Kong MX, Ren Q, Wang B, Cangiarella J and Sun W. The occurrence of papillary thyroid carcinoma in patients undergoing thyroidectomy for Hurthle cell adenoma: a comparative study. XXIX Congress of the International Academy of Pathology 2012, Cape Town, South Africa, 09/29-10/05/2012.

6. Kong MX, Ligr M, Sarpel U, Lee L, Ren Q, Cho M, Hadju C, Konno F, Taboada S, Lee P and Xu R. Over-expression of TIF1gamma is a common event in hepatocellular carcinoma irrespective of viral etiology and neoadjuvant therapy. XXIX Congress of the International Academy of Pathology 2012, Cape Town, South Africa, 09/29-10/05/2012.

7. Kong MX, Zhao X, Kheterpal E, Lee P, Taneja S, Melamed J and Deng FM. Histopathologic and Clinical Features of Vesical Diverticula. USCAP 2012,Vancouver, Canada, Mar. 17-23, 2012.

8. Hale C, Kong MX, Ren Q, et al. Decreased Stromal Androgen Receptor Expression in African-Americans with Prostate Cancer. USCAP 2012, Vancouver, Canada, Mar. 17-23, 2012.

9. Kong MX, Ren Q, Deng FM, Rosenkrantz A, Taneja S, Melamed J, Mendrinos S. Unilateral adenocarcinoma and high grade prostatic intraepithelial neoplasia in prostatectomies. Possible implication for patient care. ASCP 2011 annual meeting/WASPaLM XXVI world congress, Las Vegas, Oct. 19-22, 2011.

10. Kong MX, Hale C, Subietas-Mayol A, Cassai ND, McRae G, Goldfarb DS, Zhou M, Wieczorek R. Bilateral tubulocystic renal cell carcinomas associated with acquired end-stage renal disease: The first case report with cytogenetic and ultrastructural studies. ASCP 2011 annual meeting/WASPaLM XXVI world congress, Las Vegas, Oct. 19-22, 2011.

11. Konno F, Kong X, Wang J, Hajdu CH and Xu R. Predictive value of histological findings in postperfusion liver biopsy for onset of rejection and hepatitis C recurrence in liver allografts. CAP’11 The pathologists’ meeting/Gaylord Texan, Sept. 11-14,2011. Grapevine (Dellas), Texas, USA. Arch pathol Lab Med, 135, September 2011, pp1119.

12. Taboada S, Hajdu C, Lee L, Kong X and Xu R. Differences in Alcian Blue/Periodic Acid-Schiff staining are associated with differences in expression of immunohistochemical markers, Transcriptional Intermediary Factor 1γ and CD44 in diffuse-type gastric adenocarcinoma. CAP’11 The pathologists’ meeting/Gaylord Texan, Sept. 11-14, 2011. Grapevine (Dellas), Texas, USA. Arch pathol Lab Med, 135, September 2011, pp1117.

13. Sun W, Kong MX, Xu RL, Yee M, Roses D, Han E, Wang B. Over expression of TIF-1 in papillary thyroid carcinoma. Proceedings of Taiwan Society of Pathology. Asia Pacific IAP Congress. PP155, May 20-24, 2011, Taiwan.

14. Liu HG, Yao Q, Wang SY, Kong MX, Ho H, Sun W, Wang BY, Immunohistochemical expression of Sox10 in mucosal melanomas of the head and neck. Proceedings of Taiwan Society of Pathology. Asia Pacific IAP Congress. PP90, May 20-24, 2011, Taiwan.

15. Deng FM, Zhao Y, Kong X, Lee P, Melamed J. Patch TMA Construction Using Pre-Existing Slides as Source of Tissue When Paraffin Blocks Are Unavailable. Poster presentation #1910, USCAP 100th Annual meeting, San Antonio, Texas, Feb.26-Mar. 4, 2011.

16. Ding Y, Kong X and Xu R. Esophageal xanthoma: report of one case and review of the literature. The 15th Annual convention & Gala, Association of Chinese American physicians, USA (ACAP), New York, 2010

17. Neil J, Rosenkrantz A, Kong X, Melamed J, Taneja S, Taouli B. Volumetric 3D T2-weighted sequence of the prostate (SPACE): comparison with conventional 2D T2 for image quality and tumor detection. Proceedings of the 17th Annual Meeting of the ISMRM, Honolulu, 2009 (4258).

18. Rosenkrantz A, Kopec M, Kong X, Melamed J, Taneja S, Lepor H, Taouli B. Utility of Quantitative T2 Signal Intensity and ADC Measurements in Differentiating Prostate Cancer From Post-Biopsy Hemorrhage. Proceedings of the 17th Annual Meeting of the ISMRM, Honolulu, 2009 (2242).

19. Kong X, Ye H, Cetin N, Small J, Lee P, Melamed J. (2008, March). A Systematic Evaluation of Histopathologic Criteria for Adenocarcinoma of Prostate Using Frozen Sections as Compared with Routine Permanent Sections. Poster presented at: USCAP;Denver, Colorado.

20. Ye H, Kong X, Lee P, Melamed J. (2008, March). Intraoperative Frozen Section Analysis of Apical Margin Biopsies during Radical Prostatectomy: Ten Year Experience from a Single Institution. Platform presented at: USCAP; Denver, Colorado.

21. Basturk O, Wei J, Kong X, Zou X, Peng Y, Melamed J, Lee P. (2008, March). MicroRNA Expression in Androgen Independent and Metastatic Prostate Cancer. Poster presented at: USCAP; Denver, Colorado.

22. Lin L, Melamed J, Kong X, Chiriboga L, Yee H, Zhang X, Wei JJ, Ligr M, Peng Y, Basch R, Lee P. (2008, March). Characterization of Nuclear Hormone Receptor Cofactor TBLR1 Expression in Adenocarcinoma of the Prostate. Poster presented at: USCAP;Denver, Colorado.

23. Peng L, Melamed J, Kong XT, ZhaoY, KsionskM, Peng Y, Lee P, Wei JJ. (2007, March). Overexpression of MicroRNA let-7c in Prostate Cancer. Poster presented at: USCAP; San Diego, CA.

24. Zhao Y, Kong X, Ksionsk M, Lee P, Bannan MB, Melamed J. (2007, March). Patch Tissue Microarray (TMA): A Novel Technique for TMA Construction Using Pre-Existing Slides as a Source of Tissue When Paraffin Blocks Are Unavailable. Poster presented at:USCAP 2007; San Diego, CA.

25. Zhao Y, Kong X, Ksionsk M, et al. An accurate method for determination of tissue thickness in paraffin blocks by Faxitron analysis: Application to tissue microarray construction.USCAP, San Antonio, Texas, Mar. 2005. Modern Pathology 18:supplement 337A, 2005

26. Zhang XM, Chiu J, Kong XT, et al. Upregulated expression of androgen receptor (AR) specific transcription corepressors in prostate cancer. USCAP, San Antonio, Texas, Mar. 2005. Modern Pathology 18:supplement 174A, 2005

27. Guo CC, Kong X, Lee P, Melamed J. Expression of mucin antigens in renal tumors. USCAP, San Antonio, Texas, Mar. 2005. Modern Pathology 18:supplement 143A, 2005

28. Kong XT, Xia TL, and Gu FL. Study of the latent carcinoma of prostate in China. SIU Montreal 1997 - Societe Internationale d’Urologie 24th World Congress, Montreal, Quebec, Canada, Sept.7-11, 1997

29. Ding Y, Yu L, Kong X, et al. Study of reverse-drug resistance and its mechanism in intrinsic drug-resistant cell line GRC-1. SIU Montreal 1997 - Societe Internationale d’Urologie 24th World Congress, Montreal, Quebec, Canada, Sept.7-11, 1997

30. Kong X, Gu FL, Xia T, et al. Expression of MDR-1 gene and its product P-glycoprotein in kidney cancer. The Third Beijing International Symposium on Recent Advances in Urology (BISU’95) Beijing, China, Oct.11-14, 1995

31. Kong X, Ding Y, et al. Intrinsic multidrug resistance in human kidney cancer cell line GRC-1. The Third Beijing International Symposium on Recent Advances in Urology (BISU’95) Beijing, China, Oct.11-14, 1995

32. Kong X, Xia TL, Gu FL, et al. Latent carcinoma of prostate in China. The Third Beijing International Symposium on Recent Advances in Urology (BISU’95) Beijing, China, Oct.11-14, 1995